#StockInNews | Biocon: Arm gets US FDA’s approval for Dapagliflozin tablets, 5 mg & 10 mg

#StockInNews | HFCL arm bags order worth ₹1,366 Cr for supply of optical fiber cables

#RupeeCheck | Rupee opens at 92.64/$ Vs Tuesday's close of 93/$

#NewsAlert | India’s 10-year bond yield drops 10 bps on Iran ceasefire

#Market opens sharply higher, #Nifty near 23,900 on US-Iran 2-week ceasefire

All #Nifty stocks open higher except #ONGC; #InterGlobeAviation, L&T, #AdaniEnt & #AdaniPorts are the top gainers

#NiftyBank up over 4%, all constituents open in the green

#OMCs sharply higher after #Brent falls over 13% on US‑Iran two‑week ceasefire; #BPCL up nearly 8%

#InterGlobeAviation hits 10% upper circuit, L&T jumps over 7% on US-Iran 2-week ceasefire

#JustIn | #TVSMotor launches the #Armado200 in #Indonesia at a starting price of ₹1.8 lk

#NewsAlert | Sergio Gor, US Ambassador to India, says he had an “outstanding” dinner with Donald Trump, discussing global stability, key achievements and the future of India-US ties

#BREAKING | US President Trump says A big day for World Peace! Iran wants it to happen, they’ve had enough!

#JustIn | #ZydusLife receives final #USFDA approval for #DapagliflozinTablets

Dapagliflozin Tablets has annual sales of $10.2 Bn in the United States

Alert: Dapagliflozin Tablets is indicated for treatment of adults with type 2 Diabetes

#RBIPolicy | RBI's Monetary Policy Committee keeps #RepoRate unchanged at 5.25%

Reserve Bank of India holds rates steady at 5.25% with a neutral stance, flags West Asia risks and rising global uncertainty even as India’s fundamentals remain strong.

RBIPolicy | #MSF & #SDF rates maintained at 5.50% & 5% respectively

#RBIPolicy | #RBI decides to maintain Policy stance #NEUTRAL

#RBIPolicy | #FY26 #RealGDP growth projection increased to 7.6% from 7.4%

#RBIPolicy | #FY27CPI projected at 4.6%; #Q1FY27 CPI inflation projection unchanged at 4%, while #Q2FY27 CPI inflation projection raised to 4.4% versus 4.2% earlier

US court allows Adani to move dismissal plea in SEC case.

There is no ruling on merits yet, with both sides directed to coordinate and schedule the hearing.

#RBIPolicyReport | Baseline assumption for projections at $85/bbl in #FY27 & $75/bbl in #FY28

Baseline exchange rate assumption at 94/$ during FY27 for projections

#RBIPolicy | #Q1FY27 GDP growth estimate revised to 6.8% from 6.9% earlier, #RBI revises #Q2FY27 GDP growth to 6.7% from 7.0% earlier

#StockInNews | Hyundai Motor India to increase car prices up to 1% effective May 2026